Making the communiqué, country director for Nigeria, and the East Africa region Enrico Liggeri said, 'the opening of the distribution hub in Nairobi is part of Pfizer's commitment to making its products more accessible while ensuring consumers get the right quality products that Pfizer is known worldwide for'.
He added that the hub will serve as a legitimate supply system of products, bringing them closer to the market and reducing the total accumulated cost per product.
Pfizer has so far invested close to USD500,000 in the setting up of systems to ensure the workability of the hub.
It has also made significant social investment in Kenya and East Africa, key of these programmes include the Diflucan partnership commissioned in 2000 to improve the quality of life for people living with HIV and AIDS, anti-malaria campaigns, financial support for the Eldoret Academic model providing access to health AMPATH and donation of growth hormone medication (genotropin) to Gertrude children's hospital Nairobi.
It has partnered with pharmaceutical health distributor PHD to set up a hub earlier in the year as a response to the growing needs to ensure stable supply, secure and ultimately cheaper Pfizer products in the East Africa.
Enrico also said that the hub will to a large extent help manage counterfeit and accountability challenges which the company has been grappling with in the region.